Cargando…
Identification of IKZF1 genetic mutations as new molecular subtypes in acute myeloid leukaemia
BACKGROUND: Genetic mutations of IKZF1 have been frequently delineated in B‐lineage acute leukaemia (B‐ALL) but rarely elucidated in acute myeloid leukaemia (AML). IKZF1 mutations confer a poor prognosis in AML, and hotspot mutations of IKZF1, N159Y and N159S tend to occur in B‐ALL and AML respectiv...
Autores principales: | Wang, Yang, Cheng, Wenyan, Zhang, Yvyin, Zhang, Yuliang, Sun, Tengfei, Zhu, Yongmei, Yin, Wei, Zhang, Jianan, Li, Jianfeng, Shen, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285267/ https://www.ncbi.nlm.nih.gov/pubmed/37345307 http://dx.doi.org/10.1002/ctm2.1309 |
Ejemplares similares
-
The clinical impact of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2023) -
The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2020) -
Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
por: Zhang, Yvyin, et al.
Publicado: (2023) -
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
por: Eckardt, Jan-Niklas, et al.
Publicado: (2023) -
Identification of germline monoallelic mutations in IKZF2 in patients with immune dysregulation
por: Shahin, Tala, et al.
Publicado: (2022)